PDCD1 and hepatocellular carcinoma: For example, the hepatocellular carcinoma (HCC) exosomal circCCAR1 can be delivered to CD8 + T cells and stabilize PD1 expression to promote CD8 + T cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma [18].